Department of Plastic Surgery, Assaf Harofeh Medical Center, Zerifin, Israel.
Head Neck. 2013 Sep;35(9):1265-8. doi: 10.1002/hed.23114. Epub 2012 Aug 21.
Studies have focused on enhancing flap viability using superoxide dismutase (SOD), but only a few used SOD from human origin, and most gave the compound systemically. We evaluated the ability of SOD to improve random skin flap survival using human recombinant copper-zinc superoxide dismutase (Hr-CuZnSOD) in variable doses, injected intradermally into the flap.
Seventy male Sprague Dawley rats were randomly assigned into 4 groups. Cephalic random pattern flaps were elevated on their backs and intradermal injections of different dosages of Hr-CuZnSOD were given 15 minutes before surgery. Flap survival was evaluated by fluorescein fluorescence. Analysis of variance (ANOVA) and t test statistical analyses were performed.
Flap survival in all treated groups was significantly better than in the controls.
The beneficial effect of HR-CuZnSOD on flap survival is attained when it is given intradermally into the flap tissue. Theoretically, Hr-CuZnSOD delivered with local anesthetics used in flap elevation may be a valuable clinical tool.
研究集中于使用超氧化物歧化酶 (SOD) 来提高皮瓣的存活率,但只有少数研究使用了来源于人体的 SOD,而且大多数是将化合物进行全身给药。我们评估了使用不同剂量的人重组铜锌超氧化物歧化酶 (Hr-CuZnSOD) 通过皮内注射到皮瓣中来提高随意皮瓣存活的能力。
70 只雄性 Sprague Dawley 大鼠被随机分为 4 组。在背部掀起头部随意皮瓣,并在手术前 15 分钟给予不同剂量的 Hr-CuZnSOD 皮内注射。通过荧光素荧光评估皮瓣存活。采用方差分析 (ANOVA) 和 t 检验进行统计学分析。
所有治疗组的皮瓣存活率均明显优于对照组。
当将 Hr-CuZnSOD 皮内注射到皮瓣组织中时,可获得对皮瓣存活的有益效果。理论上,在掀起皮瓣时使用的局部麻醉剂中递送的 Hr-CuZnSOD 可能是一种有价值的临床工具。